tiprankstipranks
Trending News
More News >
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Income Statement

Compare
2,366 Followers

Aquestive Therapeutics Income Statement

Last quarter (Q3 2025), Aquestive Therapeutics's total revenue was $12.81M, a decrease of -5.43% from the same quarter last year. In Q3, Aquestive Therapeutics's net income was $-15.45M. See Aquestive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 57.56M$ 50.58M$ 47.68M$ 50.83M$ 45.85M
Gross Profit
$ 39.69M$ 29.75M$ 28.29M$ 35.84M$ 32.88M
Operating Expenses
$ 70.46M$ 44.85M$ 70.36M$ 70.52M$ 75.78M
Depreciation and Amortization
$ 718.00K$ 1.34M$ 2.39M$ 2.96M$ 3.61M
EBITDA
$ -26.62M$ 1.18M$ -39.58M$ -45.11M$ -39.15M
Operating Income
$ -30.77M$ -15.10M$ -42.07M$ -34.68M$ -42.89M
Other Income/Expenses
$ -13.38M$ 7.48M$ -12.34M$ -35.86M$ -12.89M
Pretax Income
$ -44.15M$ -7.63M$ -54.41M$ -70.54M$ -55.78M
Net Income
$ -44.14M$ -7.87M$ -54.41M$ -70.54M$ -55.78M
Per Share Metrics
Basic EPS
$ -0.51$ -0.13$ -1.12$ -1.85$ -1.66
Diluted EPS
$ -0.51$ -0.13$ -1.12$ -1.85$ -1.66
Weighted Average Shares Outstanding
86.73M 61.26M 48.73M 38.08M 33.65M
Weighted Average Shares Outstanding (Diluted)
86.73M 61.26M 48.73M 38.08M 33.65M
Currency in USD

Aquestive Therapeutics Earnings and Revenue History